Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Liabilities and Shareholders Equity: 2023-2024

Historic Liabilities and Shareholders Equity for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $78.3 million.

  • Camp4 Therapeutics' Liabilities and Shareholders Equity rose 304.40% to $86.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.8 million, marking a year-over-year change of. This contributed to the annual value of $78.3 million for FY2024, which is 42.52% up from last year.
  • Camp4 Therapeutics' Liabilities and Shareholders Equity amounted to $78.3 million in FY2024, which was up 42.52% from $54.9 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Liabilities and Shareholders Equity ranged from a high of $78.3 million in FY2024 and a low of $54.9 million during FY2023.
  • In the last 2 years, Camp4 Therapeutics' Liabilities and Shareholders Equity had a median value of $66.6 million in 2023 and averaged $66.6 million.
  • Data for Camp4 Therapeutics' Liabilities and Shareholders Equity shows a peak YoY soared of 42.52% (in 2024) over the last 5 years.
  • Camp4 Therapeutics' Liabilities and Shareholders Equity (Yearly) stood at $54.9 million in 2023, then soared by 42.52% to $78.3 million in 2024.